Two brokerages rate KLINIQ as the standout stock in the beauty business group, forecasting that 2026 revenue could grow beyond the 20% target, up from the 11% previously expected by research teams, after first-half results came in above target. Krungsri Securities sets a target price of 33 baht and maintains a buy recommendation, estimating full-year 2026 profit at 403 million baht. Another research house gives a fair value of 30 baht and keeps a speculative buy rating, with a full-year 2026 net profit forecast of 458 million baht, up 26% from the previous year, driven by same-store sales growth, new branch openings, and a recovery in gross margin. They also project a dividend yield as high as 5.6%.
The Klinique Med Clinic PCLBrokerages forecast revenue growth above target, higher profit, and high dividend yield
Bank of Ayudhya PCL